Online citations, reference lists, and bibliographies.

The Effect Of Various Zinc Binding Groups On Inhibition Of Histone Deacetylases 1–11

Andreas S. Madsen, Helle M. E. Kristensen, G. Lanz, C. Olsen
Published 2014 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Histone deacetylases (HDACs) have the ability to cleave the acetyl groups of ε‐N‐acetylated lysine residues in a variety of proteins. Given that human cells contain thousands of different acetylated lysine residues, HDACS may regulate a wide variety of processes including some implicated in conditions such as cancer and neurodegenerative disorders. Herein we report the synthesis and in vitro biochemical profiling of a series of compounds, including known inhibitors as well as novel chemotypes, that incorporate putative new zinc binding domains. By evaluating the compound collection against all 11 recombinant human HDACs, we found that the trifluoromethyl ketone functionality provides potent inhibition of all four subclasses of the Zn2+‐dependent HDACs. Potent inhibition was observed with two different scaffolds, demonstrating the efficiency of the trifluoromethyl ketone moiety as a zinc binding motif. Interestingly, we also identified silanediol as a zinc binding group with potential for future development of non‐hydroxamate class I and class IIb HDAC inhibitors.
This paper references
10.1021/JM980565U
Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives.
T. Suzuki (1999)
10.1021/ML300081U
HDAC Inhibitors without an Active Site Zn2+-Binding Group
Chris J. Vickers (2012)
10.1021/ja01591a065
A New Synthesis of Ketones Containing One Perfluoroalkyl Group1,2
Kenneth T. Dishart (1956)
10.1002/anie.199104381
Synthesis and Structure of a rac‐Tris(divinyldisiloxane) diplatinum(0) Complex and its Reaction with Maleic Anhydride
P. Hitchcock (1991)
Proteomics 2011, 10, DOI: 10.1074/mcp.M111.012658
a Z. Zhang (2011)
10.1021/jo300175t
Synthesis and properties of a sterically unencumbered δ-silanediol amino acid.
J. Kim (2012)
10.1038/nrd2681
Therapeutic application of histone deacetylase inhibitors for central nervous system disorders
A. Kazantsev (2008)
10.1038/nrg2485
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
M. Haberland (2009)
10.1002/anie.201200316
Expansion of the lysine acylation landscape.
C. Olsen (2012)
Chem
T. Suzuki
10.1021/jm900555u
Identification of novel, selective, and stable inhibitors of class II histone deacetylases. Validation studies of the inhibition of the enzymatic activity of HDAC4 by small molecules as a novel approach for cancer therapy.
J. Ontoria (2009)
10.1021/JM010826R
A structure-based design approach to the development of novel, reversible AChE inhibitors.
C. Doucet-Personeni (2001)
10.1016/J.TET.2009.11.053
Synthesis of 2-aryl-3,3,3-trifluoropropanoic acids using electrochemical carboxylation of (1-bromo-2,2,2-trifluoroethyl)arenes and its application to the synthesis of β,β,β-trifluorinated non-steroidal anti-inflammatory drugs
Yusuke Yamauchi (2010)
10.1021/ja809508f
Design, synthesis, biological evaluation, and structural characterization of potent histone deacetylase inhibitors based on cyclic alpha/beta-tetrapeptide architectures.
A. Montero (2009)
10.1016/j.bmcl.2009.04.011
Histone deacetylase inhibitors with a primary amide zinc binding group display antitumor activity in xenograft model.
Barbara Attenni (2009)
10.1016/j.bmcl.2008.09.076
2-Trifluoroacetylthiophene oxadiazoles as potent and selective class II human histone deacetylase inhibitors.
E. Muraglia (2008)
10.1021/jm00008a020
The synthesis of N-hydroxy-N'-phenyloctanediamide and its inhibitory effect on proliferation of AXC rat prostate cancer cells.
J. C. Stowell (1995)
10.1021/jm900850t
Discovery of potent and selective histone deacetylase inhibitors via focused combinatorial libraries of cyclic alpha3beta-tetrapeptides.
C. Olsen (2009)
10.1007/s00894-012-1745-0
Quantum chemical study of silanediols as metal binding groups for metalloprotease inhibitors
I. Ignatyev (2013)
10.1021/JO070739S
Zinc binding in HDAC inhibitors: a DFT study.
D. Wang (2007)
10.1038/nbt.1759
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
M. Bantscheff (2011)
10.1021/ja7110064
Structure and activity of largazole, a potent antiproliferative agent from the Floridian marine cyanobacterium Symploca sp.
Kanchan Taori (2008)
10.1038/nchembio.275
Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis.
D. Hutt (2010)
10.1002/ange.19911030419
Synthese und Struktur eines rac-Tris(divinyldisiloxan)diplatin(0)-Komplexes und dessen Reaktion mit Maleinsäureanhydrid†
P. Hitchcock (1991)
10.1021/jo801737c
Trifluoromethyl ketones from enolizable carboxylic acids via enediolate trifluoroacetylation/decarboxylation.
J. T. Reeves (2008)
Steink hler, Bioorg
R. R. Frey (2002)
10.1073/PNAS.93.23.13143
Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase.
S. Darkin-Rattray (1996)
10.1021/JA0341440
Structural biasing elements for in-cell histone deacetylase paralog selectivity.
J. C. Wong (2003)
10.1038/nature10849
An epigenetic blockade of cognitive functions in the neurodegenerating brain
J. Gräff (2012)
10.1021/JM049207J
Novel inhibitors of human histone deacetylases: design, synthesis, enzyme inhibition, and cancer cell growth inhibition of SAHA-based non-hydroxamates.
T. Suzuki (2005)
10.1016/J.BMCL.2004.08.016
Novel histone deacetylase inhibitors: cyclic tetrapeptide with trifluoromethyl and pentafluoroethyl ketones.
B. Jose (2004)
10.1021/ja804720p
Sequential C-Si bond formations from diphenylsilane: application to silanediol peptide isostere precursors.
L. Nielsen (2008)
10.1016/J.BMCL.2004.03.063
Thiol-based SAHA analogues as potent histone deacetylase inhibitors.
T. Suzuki (2004)
10.1021/ja904709b
Pd(II)-catalyzed amination of C-H bonds using single-electron or two-electron oxidants.
T. Mei (2009)
10.1021/jo00239a010
.alpha.-Trifluoromethyl-destabilized cations. A route to 1-(trifluoromethyl)tetralins by trifluoroacetolysis of 5-aryl-1,1,1-trifluoropentan-2-ols and derivatives
D. Bonnet-Delpon (1988)
10.1016/j.bmcl.2010.03.091
Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides.
J. C. Bressi (2010)
10.1126/science.1175371
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
C. Choudhary (2009)
10.1073/PNAS.96.8.4592
A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors.
A. Saito (1999)
10.1021/OL0400589
Synthesis of 5-bromopyridyl-2-magnesium chloride and its application in the synthesis of functionalized pyridines.
J. Song (2004)
10.1016/0040-4020(95)00006-T
A new and efficient synthesis of trifluoromethyl ketones from carboxylic acids. Part I
J. Boivin (1995)
10.1002/(SICI)1521-3757(19980316)110:6<845::AID-ANGE845>3.0.CO;2-X
Silandiole: eine neue Klasse potenter Protease‐Inhibitoren
S. M. Sieburth (1998)
10.1002/JLCR.1122
Radiosynthesis of 6-([18F]fluoroacetamido)-1-hexanoic-anilide ([18F]FAHA) for PET imaging of histone deacetylase (HDAC)
U. Mukhopadhyay (2006)
10.1007/BF00905943
Synthesis of fluorinated ketones by means of organolithium compounds and N, N-dialkyl amides of fluorinated acids
N. A. Zaitseva (1961)
FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases.
R. Furumai (2002)
Signals from NCH 3 , CONCH 3 and CH 2 CONCH 3 were very weak in 13 C NMR, probably due to fast quadrupolar relaxation via the nearby 14 N nuclei
10.1038/nchembio.1223
Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group.
M. Lobera (2013)
10.1016/j.cell.2007.02.005
Chromatin Modifications and Their Function
T. Kouzarides (2007)
10.1016/J.JMB.2005.09.065
Crystal structure of a bacterial class 2 histone deacetylase homologue.
T. K. Nielsen (2005)
10.1021/JM060554Y
Highly potent and selective histone deacetylase 6 inhibitors designed based on a small-molecular substrate.
T. Suzuki (2006)
10.1021/jm401053m
Investigating the selectivity of metalloenzyme inhibitors.
Joshua A Day (2013)
10.1038/nrd2133
Anticancer activities of histone deacetylase inhibitors
J. E. Bolden (2006)
10.1016/j.cmet.2011.10.006
Old enzymes, new tricks: sirtuins are NAD(+)-dependent de-acylases.
M. Hirschey (2011)
10.1016/j.cell.2011.08.008
Identification of 67 Histone Marks and Histone Lysine Crotonylation as a New Type of Histone Modification
M. Tan (2011)
10.1021/JM701079H
Novel aminophenyl benzamide-type histone deacetylase inhibitors with enhanced potency and selectivity.
O. Moradei (2007)
10.1016/J.BMCL.2003.10.055
Design, synthesis, and activity of HDAC inhibitors with a N-formyl hydroxylamine head group.
T. Wu (2004)
10.1021/JO701907D
Stereocontrolled synthesis of methyl silanediol peptide mimics.
L. Nielsen (2007)
10.1021/ML1001954
Short-Chain HDAC Inhibitors Differentially Affect Vertebrate Development and Neuronal Chromatin
D. M. Fass (2011)
10.1007/s13311-013-0226-1
Small Molecule Inhibitors of Zinc-dependent Histone Deacetylases
F. Wagner (2013)
10.1073/PNAS.93.12.5705
Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.
V. Richon (1996)
10.1038/nbt1272
Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug
P. Marks (2007)
10.1016/j.ejmech.2010.02.030
Inside HDAC with HDAC inhibitors.
P. Bertrand (2010)
10.1021/JO000458J
Regioselective intramolecular oxidation of phenols and anisoles by dioxiranes generated in situ
Yang (2000)
10.1016/J.TETLET.2006.11.068
Direct conversion of primary and secondary carboxylic acids to trifluoromethyl ketones
J. Reeves (2007)
10.1021/jo01070a015
Syntheses and Facile Cleavage of Five-Membered Ring Sultams1
W. F. Erman (1961)
10.1016/j.bmcl.2008.02.026
2-Trifluoroacetylthiophenes, a novel series of potent and selective class II histone deacetylase inhibitors.
P. Jones (2008)
10.1016/J.JMB.2004.02.006
Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis.
Ivan V. Gregoretti (2004)
10.1016/J.MOLCEL.2006.06.026
Substrate and functional diversity of lysine acetylation revealed by a proteomics survey.
S. Kim (2006)
10.1016/J.BMCL.2004.06.076
Discovery of isoxazolinone antibacterial agents. Nitrogen as a replacement for the stereogenic center found in oxazolidinone antibacterials.
L. Snyder (2004)
10.1016/J.BMCL.2003.09.048
Novel histone deacetylase inhibitors: design, synthesis, enzyme inhibition, and binding mode study of SAHA-based non-hydroxamates.
T. Suzuki (2003)
10.1016/S1074-5521(03)00095-4
Multidimensional chemical genetic analysis of diversity-oriented synthesis-derived deacetylase inhibitors using cell-based assays.
S. Haggarty (2003)
10.1016/j.bmcl.2008.11.081
Sulfamides as novel histone deacetylase inhibitors.
Amal Wahhab (2009)
10.1016/j.bmcl.2008.02.025
Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases.
P. Jones (2008)
Hydrated upon standing, giving the hydrate exclusively
10.1021/jo00231a036
Reaction of organometallic reagents with ethyl trifluoroacetate and diethyl oxalate. Formation of trifluoromethyl ketones and .alpha.-keto esters via stable tetrahedral adducts
X. Creary (1987)
10.1074/jbc.C113.511261
Activation of the Protein Deacetylase SIRT6 by Long-chain Fatty Acids and Widespread Deacylation by Mammalian Sirtuins* ♦
Jessica L Feldman (2013)
10.1016/S0040-4039(01)00081-8
A general and versatile synthesis of 2-alkyl-4-aminopyridines
Vidyadhar B. Hegde (2001)
10.1016/S0040-4020(01)90870-1
Pyridyl and N,N-dimethylanilyltrifluoromethylketones forming stable gem-diols
R. Salvador (1971)
Radiopharm
U. Mukhopadhyay
Chem
J. K. Kim
10.1021/ar300200h
Efficient routes to carbon-silicon bond formation for the synthesis of silicon-containing peptides and azasilaheterocycles.
G. Min (2013)
10.1021/jm300526r
Substrates for efficient fluorometric screening employing the NAD-dependent sirtuin 5 lysine deacylase (KDAC) enzyme.
Andreas S. Madsen (2012)
10.1021/ja105119r
An aldol-based build/couple/pair strategy for the synthesis of medium- and large-sized rings: discovery of macrocyclic histone deacetylase inhibitors.
L. A. Marcaurelle (2010)
10.1021/jm4008449
Total synthesis and full histone deacetylase inhibitory profiling of Azumamides A-E as well as β²- epi-Azumamide E and β³-epi-Azumamide E.
J. Villadsen (2013)
10.1016/S0960-894X(03)00685-1
α-Keto amides as inhibitors of histone deacetylase
C. Wada (2003)
10.1021/ml300081u
Discovery of HDAC Inhibitors That Lack an Active Site Zn(2+)-Binding Functional Group.
Chris J. Vickers (2012)
10.1038/nature12038
Sirt6 regulates TNFα secretion via hydrolysis of long chain fatty acyl lysine
H. Jiang (2013)
10.1016/J.BMCL.2006.09.002
A series of novel, potent, and selective histone deacetylase inhibitors.
P. Jones (2006)
10.1016/0022-328X(87)80256-5
Nickel(0)-katalysierte bildung von carbocyclischen amiden aus α,ω-dienen und phenylisocyanat
E. Hernandez (1987)
10.1016/S0960-894X(02)00754-0
Trifluoromethyl ketones as inhibitors of histone deacetylase.
R. Frey (2002)
10.1021/jm7011408
Histone deacetylase inhibitors: from bench to clinic.
M. Paris (2008)
10.1074/jbc.M803514200
Structural and Functional Analysis of the Human HDAC4 Catalytic Domain Reveals a Regulatory Structural Zinc-binding Domain*
M. Bottomley (2008)
10.1074/jbc.M807045200
Pimelic Diphenylamide 106 Is a Slow, Tight-binding Inhibitor of Class I Histone Deacetylases*
C. J. Chou (2008)
10.1002/anie.201203754
Profiling of substrates for zinc-dependent lysine deacylase enzymes: HDAC3 exhibits decrotonylase activity in vitro.
Andreas S. Madsen (2012)
10.1002/ps.2780410205
Inhibition of pheromone action in Sesamia nonagrioides by haloacetate analogues
M. Riba (1994)
10.1002/ANGE.201200316
Acylierung von Lysinen: Erweiterung des Repertoires
C. Olsen (2012)
10.1073/pnas.0706487104
Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases
A. Lahm (2007)
10.1002/EJOC.200500508
Silanediol Protease Inhibitors: From Conception to Validation†
S. M. Sieburth (2006)
10.1021/OM040127N
The SiOH-Containing α-Amino Acid HOMe2SiCH2CH(NH2)COOH and Its Immobilization on Silica via an Si−O−Si Linkage
R. Tacke (2005)
10.1021/jm3010114
Organosilicon molecules with medicinal applications.
A. Franz (2013)
Hydrated upon standing, giving the ketone and hydrate in~1:1 ratio
Chem
J. C. Stowell
10.1021/ML200136E
Potential Agents for Treating Cystic Fibrosis: Cyclic Tetrapeptides that Restore Trafficking and Activity of ΔF508-CFTR.
D. Hutt (2011)
10.1016/j.bmcl.2011.07.100
Synthesis of a new trifluoromethylketone analogue of l-arginine and contrasting inhibitory activity against human arginase I and histone deacetylase 8.
M. Ilies (2011)
10.1016/S0040-4039(00)84846-7
Microbiological synthesis of variously protected L-glyceraldehydes in high optical purity
G. Guanti (1986)
10.1038/nchembio.495
Identification of lysine succinylation as a new post-translational modification.
Z. Zhang (2011)
10.1371/journal.pone.0072871
Heterologous Reconstitution of the Intact Geodin Gene Cluster in Aspergillus nidulans through a Simple and Versatile PCR Based Approach
M. Nielsen (2013)
10.1002/(SICI)1521-3773(19980403)37:6<812::AID-ANIE812>3.0.CO;2-I
Silanediols: A New Class of Potent Protease Inhibitors.
S. Sieburth (1998)
10.1021/jo00013a034
Preparation and utility of dianions from N-tert-butylthiophene-2-sulfonamide
S. Graham (1991)
10.1126/science.1207861
Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase
J. Du (2011)
10.1021/JM061273T
Quinol-4-ones as steroid A-ring mimetics in nonsteroidal dissociated glucocorticoid agonists.
J. Regan (2006)
10.1126/science.1179689
Regulation of Cellular Metabolism by Protein Lysine Acetylation
S. Zhao (2010)
10.1021/ja8013727
Total synthesis and molecular target of largazole, a histone deacetylase inhibitor.
Yongcheng Ying (2008)
10.1038/NCHEMBIO.313
Chemical Phylogenetics of Histone Deacetylases
J. Bradner (2010)
10.1016/J.BMCL.2007.11.047
Optimization of biaryl Selective HDAC1&2 Inhibitors (SHI-1:2).
David J Witter (2008)
10.1016/j.bmcl.2012.08.104
Novel histone deacetylase 8 ligands without a zinc chelating group: exploring an 'upside-down' binding pose.
A. Vaidya (2012)
10.1021/ml300162r
Macrocyclic peptoid-Peptide hybrids as inhibitors of class I histone deacetylases.
C. Olsen (2012)
10.1038/nrc1779
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
S. Minucci (2006)
10.1016/J.JFLUCHEM.2010.03.013
Determination of pKa values of fluoroalkanesulfonamides and investigation of their nucleophilicity
Cheng-Pan Zhang (2010)
10.1016/j.bmcl.2007.12.031
Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2).
Joey L Methot (2008)
Chem
K. T. Dishart



This paper is referenced by
10.3762/bjoc.11.270
Diversity-oriented synthesis of analogues of the novel macrocyclic peptide FR-225497 through late stage functionalization
Jyotiprasad Mukherjee (2015)
10.4274/tjps.75047
Histone Deacetylase Inhibitors: A Prospect in Drug Discovery
Rakesh Yadav (2019)
10.1021/acs.orglett.5b01344
A Convergent Radical Based Route to Trifluoromethyl Ketones and to α,β-Unsaturated Trifluoromethyl Ketones.
Lucile Anthore (2015)
10.17179/excli2017-208
Microwave-assisted synthesis and antitumor evaluation of a new series of thiazolylcoumarin derivatives
Moustafa T Gabr (2017)
10.1016/j.bmcl.2016.03.116
A sub-milligram-synthesis protocol for in vitro screening of HDAC11 inhibitors.
Yinping Tian (2016)
10.3390/molecules23051166
Clinically Applicable Inhibitors Impacting Genome Stability
Anu Prakash (2018)
10.1021/acs.jmedchem.5b01632
Design and Synthesis of Simplified Largazole Analogues as Isoform-Selective Human Lysine Deacetylase Inhibitors.
D. N. Reddy (2016)
10.1039/c7ob02862h
Convenient, functional group-tolerant, transition metal-free synthesis of aryl and heteroaryl trifluoromethyl ketones with the use of methyl trifluoroacetate.
Kazumasa Funabiki (2018)
10.1002/chem.201605140
A Fluorescence-Lifetime-Based Binding Assay for Class IIa Histone Deacetylases.
C. Meyners (2017)
10.1515/hsz-2018-0363
Kinetically selective and potent inhibitors of HDAC8
Markus Schweipert (2019)
10.1016/j.bmc.2015.04.028
Discovery, bioactivity and docking simulation of Vorinostat analogues containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors and antitumor agents.
J. Cai (2015)
10.1039/C5MD00451A
A potent trifluoromethyl ketone histone deacetylase inhibitor exhibits class-dependent mechanism of action
Andreas Stahl Madsen (2016)
10.1002/EJOC.201403441
Preparation and Catalytic Activity of BINOL‐Derived Silanediols
Joshua M. Wieting (2015)
10.1016/j.chembiol.2018.04.007
Histone Deacetylase 11 Is an ε-N-Myristoyllysine Hydrolase.
Carlos Moreno-Yruela (2018)
10.1002/9783527809257.CH7
Inhibitors of the Zinc‐Dependent Histone Deacetylases
Helle M. E. Kristensen (2019)
10.1039/c5cc10445a
Photo-induced coupling reactions of tetrazoles with carboxylic acids in aqueous solution: application in protein labelling.
Shan Zhao (2016)
10.1039/C4MD00471J
Application of QM/MM and QM methods to investigate histone deacetylase 8
Duangkamol Gleeson (2015)
10.4155/fmc-2016-0193
Progress in the medicinal chemistry of silicon: C/Si exchange and beyond.
Shinya Fujii (2017)
10.1002/open.201800117
SAHAquines, Novel Hybrids Based on SAHA and Primaquine Motifs, as Potential Cytostatic and Antiplasmodial Agents
Maja Beus (2018)
10.1016/J.JFLUCHEM.2015.01.015
A practical synthesis of trifluoromethyl alkyl ketones
Dongmei Yang (2015)
10.1002/anie.201701026
Inhibiting Polysulfide Shuttle in Lithium-Sulfur Batteries through Low-Ion-Pairing Salts and a Triflamide Solvent.
A. Shyamsunder (2017)
10.3390/md18040179
Assessment of the Allelochemical Activity and Biochemical Profile of Different Phenotypes of Picocyanobacteria from the Genus Synechococcus
Zofia Konarzewska (2020)
10.1016/j.ejmech.2016.02.003
Design, synthesis and biological evaluation of bisthiazole-based trifluoromethyl ketone derivatives as potent HDAC inhibitors with improved cellular efficacy.
Chao-Jun Gong (2016)
Development of a UV-Cleavable Protecting Group for Hydroxylamines, Synthesis of a StructurallyWide Variety of Hydroxamic Acids, and Identification of Histone Deacetylase Inhibitors
Kim T. Mortensen (2017)
10.1021/acs.jmedchem.7b00718
Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds.
R. Ramesh (2018)
10.1016/j.bmcl.2015.09.006
Investigation on the ZBG-functionality of phenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase inhibitors.
L. Musso (2015)
10.1016/j.bbrc.2014.07.006
Development and classes of epigenetic drugs for cancer.
D. Dhanak (2014)
10.1517/17460441.2014.930124
Epigenetic drug discovery for Alzheimer’s disease
R. Cacabelos (2014)
10.1016/j.cbpa.2016.12.011
Developing drugs targeting transition metal homeostasis.
Claire M Weekley (2017)
10.2147/DDDT.S110997
Novel glyoxalase-I inhibitors possessing a “zinc-binding feature” as potential anticancer agents
Qosay A Al-Balas (2016)
10.1021/jm500984b
Exploring the Influence of the Protein Environment on Metal-Binding Pharmacophores
D. P. Martin (2014)
10.1021/acs.biochem.7b00725
Chemical Editing of Macrocyclic Natural Products and Kinetic Profiling Reveal Slow, Tight-Binding Histone Deacetylase Inhibitors with Picomolar Affinities.
Betuel Kitir (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar